Nadk2 Mouse (+)-dexrazoxane multiple interactions EXP 6480464 [Doxorubicin co-treated with Dexrazoxane] results in increased expression of NADK2 mRNA CTD PMID:26873546 Nadk2 Mouse (+)-schisandrin B multiple interactions ISO RGD:1306809 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NADK2 mRNA] CTD PMID:31150632 Nadk2 Mouse (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1604237 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NADK2 mRNA CTD PMID:22079256 Nadk2 Mouse 17beta-estradiol increases expression ISO RGD:1604237 6480464 Estradiol results in increased expression of NADK2 mRNA CTD PMID:19167446 Nadk2 Mouse 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of NADK2 mRNA CTD PMID:39298647 Nadk2 Mouse 17beta-estradiol multiple interactions ISO RGD:1306809 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of NADK2 mRNA CTD PMID:26496021 Nadk2 Mouse 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1306809 6480464 Tetrachlorodibenzodioxin affects the expression of NADK2 mRNA CTD PMID:22298810 Nadk2 Mouse 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1604237 6480464 [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of NADK2 mRNA CTD PMID:29704546 Nadk2 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1306809 6480464 Tetrachlorodibenzodioxin results in decreased expression of NADK2 mRNA CTD PMID:21215274|PMID:21724226|PMID:32109520 Nadk2 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1604237 6480464 Tetrachlorodibenzodioxin results in decreased expression of NADK2 mRNA CTD PMID:20106945|PMID:21632981 Nadk2 Mouse 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:1306809 6480464 2,3,7,8-tetrachlorodibenzofuran results in decreased expression of NADK2 mRNA CTD PMID:32109520 Nadk2 Mouse 4,4'-sulfonyldiphenol decreases expression EXP 6480464 bisphenol S results in decreased expression of NADK2 mRNA CTD PMID:39298647 Nadk2 Mouse 4,4'-sulfonyldiphenol increases expression ISO RGD:1604237 6480464 bisphenol S results in increased expression of NADK2 protein CTD PMID:34186270 Nadk2 Mouse 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of NADK2 mRNA CTD PMID:28973697 Nadk2 Mouse 6-propyl-2-thiouracil increases expression ISO RGD:1306809 6480464 Propylthiouracil results in increased expression of NADK2 mRNA CTD PMID:24780913 Nadk2 Mouse 6-propyl-2-thiouracil decreases expression ISO RGD:1306809 6480464 Propylthiouracil results in decreased expression of NADK2 mRNA CTD PMID:30047161 Nadk2 Mouse acetamide decreases expression ISO RGD:1306809 6480464 acetamide results in decreased expression of NADK2 mRNA CTD PMID:31881176 Nadk2 Mouse acrolein multiple interactions ISO RGD:1604237 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of more ... CTD PMID:32699268 Nadk2 Mouse aflatoxin B1 decreases expression ISO RGD:1604237 6480464 Aflatoxin B1 results in decreased expression of NADK2 mRNA CTD PMID:27153756 Nadk2 Mouse aflatoxin B1 decreases methylation ISO RGD:1604237 6480464 Aflatoxin B1 results in decreased methylation of NADK2 gene CTD PMID:27153756 Nadk2 Mouse all-trans-retinoic acid decreases expression ISO RGD:1604237 6480464 Tretinoin results in decreased expression of NADK2 mRNA CTD PMID:33167477 Nadk2 Mouse alpha-pinene multiple interactions ISO RGD:1604237 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of more ... CTD PMID:32699268 Nadk2 Mouse amitrole decreases expression ISO RGD:1306809 6480464 Amitrole results in decreased expression of NADK2 mRNA CTD PMID:30047161 Nadk2 Mouse antirheumatic drug increases expression ISO RGD:1604237 6480464 Antirheumatic Agents results in increased expression of NADK2 mRNA CTD PMID:24449571 Nadk2 Mouse aristolochic acid A decreases expression ISO RGD:1604237 6480464 aristolochic acid I results in decreased expression of NADK2 mRNA CTD PMID:33212167 Nadk2 Mouse arsane affects methylation ISO RGD:1604237 6480464 Arsenic affects the methylation of NADK2 gene CTD PMID:25304211 Nadk2 Mouse arsenic atom affects methylation ISO RGD:1604237 6480464 Arsenic affects the methylation of NADK2 gene CTD PMID:25304211 Nadk2 Mouse arsenous acid affects expression EXP 6480464 Arsenic Trioxide affects the expression of NADK2 mRNA CTD PMID:35676786 Nadk2 Mouse atrazine increases expression ISO RGD:1306809 6480464 Atrazine results in increased expression of NADK2 mRNA CTD PMID:36841081 Nadk2 Mouse benzo[a]pyrene decreases expression ISO RGD:1604237 6480464 Benzo(a)pyrene results in decreased expression of NADK2 mRNA CTD PMID:21632981 Nadk2 Mouse benzo[a]pyrene decreases methylation ISO RGD:1604237 6480464 Benzo(a)pyrene results in decreased methylation of NADK2 5' UTR; Benzo(a)pyrene results in decreased methylation of more ... CTD PMID:27901495 Nadk2 Mouse benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1604237 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NADK2 mRNA CTD PMID:20018196 Nadk2 Mouse bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1604237 6480464 [Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of NADK2 more ... CTD PMID:33872906 Nadk2 Mouse bisphenol A multiple interactions ISO RGD:1306809 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of NADK2 mRNA CTD PMID:26496021 Nadk2 Mouse bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NADK2 mRNA CTD PMID:37894381 Nadk2 Mouse bisphenol A decreases methylation ISO RGD:1604237 6480464 bisphenol A results in decreased methylation of NADK2 gene CTD PMID:31601247 Nadk2 Mouse bisphenol A increases expression ISO RGD:1306809 6480464 bisphenol A results in increased expression of NADK2 mRNA CTD PMID:33296240 Nadk2 Mouse bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NADK2 mRNA CTD PMID:26063408 Nadk2 Mouse Bisphenol B increases expression ISO RGD:1604237 6480464 bisphenol B results in increased expression of NADK2 protein CTD PMID:34186270 Nadk2 Mouse bisphenol F increases expression ISO RGD:1604237 6480464 bisphenol F results in increased expression of NADK2 protein CTD PMID:34186270 Nadk2 Mouse bortezomib increases expression ISO RGD:1604237 6480464 Bortezomib results in increased expression of NADK2 mRNA CTD PMID:20977926 Nadk2 Mouse cadmium dichloride decreases expression ISO RGD:1604237 6480464 Cadmium Chloride results in decreased expression of NADK2 mRNA CTD PMID:38568856 Nadk2 Mouse caffeine decreases phosphorylation ISO RGD:1604237 6480464 Caffeine results in decreased phosphorylation of NADK2 protein CTD PMID:35688186 Nadk2 Mouse carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon analog results in decreased expression of NADK2 mRNA; Nanotubes, Carbon results in decreased more ... CTD PMID:25554681|PMID:25620056 Nadk2 Mouse chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of NADK2 mRNA CTD PMID:37019170 Nadk2 Mouse copper(II) sulfate decreases expression ISO RGD:1604237 6480464 Copper Sulfate results in decreased expression of NADK2 mRNA CTD PMID:19549813 Nadk2 Mouse coumestrol multiple interactions ISO RGD:1604237 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of NADK2 mRNA CTD PMID:19167446 Nadk2 Mouse coumestrol increases expression ISO RGD:1604237 6480464 Coumestrol results in increased expression of NADK2 mRNA CTD PMID:19167446 Nadk2 Mouse cyclosporin A decreases expression ISO RGD:1604237 6480464 Cyclosporine results in decreased expression of NADK2 mRNA CTD PMID:25562108 Nadk2 Mouse DDE decreases expression ISO RGD:1604237 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of NADK2 mRNA CTD PMID:38568856 Nadk2 Mouse diarsenic trioxide affects expression EXP 6480464 Arsenic Trioxide affects the expression of NADK2 mRNA CTD PMID:35676786 Nadk2 Mouse dicrotophos decreases expression ISO RGD:1604237 6480464 dicrotophos results in decreased expression of NADK2 mRNA CTD PMID:28302478 Nadk2 Mouse dorsomorphin multiple interactions ISO RGD:1604237 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 Nadk2 Mouse doxorubicin multiple interactions EXP 6480464 [Doxorubicin co-treated with Dexrazoxane] results in increased expression of NADK2 mRNA CTD PMID:26873546 Nadk2 Mouse doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of NADK2 mRNA CTD PMID:26873546 Nadk2 Mouse entinostat decreases expression ISO RGD:1604237 6480464 entinostat results in decreased expression of NADK2 mRNA CTD PMID:26272509 Nadk2 Mouse entinostat multiple interactions ISO RGD:1604237 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 Nadk2 Mouse ethanol affects expression EXP 6480464 Ethanol affects the expression of NADK2 mRNA CTD PMID:30319688 Nadk2 Mouse ethanol increases expression EXP 6480464 Ethanol results in increased expression of NADK2 mRNA CTD PMID:30319688 Nadk2 Mouse ethyl methanesulfonate decreases expression ISO RGD:1604237 6480464 Ethyl Methanesulfonate results in decreased expression of NADK2 mRNA CTD PMID:23649840 Nadk2 Mouse flutamide decreases expression ISO RGD:1306809 6480464 Flutamide results in decreased expression of NADK2 mRNA CTD PMID:24793618 Nadk2 Mouse formaldehyde decreases expression ISO RGD:1604237 6480464 Formaldehyde results in decreased expression of NADK2 mRNA CTD PMID:23649840 Nadk2 Mouse fulvestrant decreases methylation ISO RGD:1604237 6480464 Fulvestrant results in decreased methylation of NADK2 gene CTD PMID:31601247 Nadk2 Mouse glafenine decreases expression ISO RGD:1306809 6480464 Glafenine results in decreased expression of NADK2 mRNA CTD PMID:24136188 Nadk2 Mouse GSK-J4 increases expression ISO RGD:1604237 6480464 GSK-J4 results in increased expression of NADK2 mRNA CTD PMID:29301935 Nadk2 Mouse inulin multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NADK2 mRNA CTD PMID:36331819 Nadk2 Mouse ivermectin decreases expression ISO RGD:1604237 6480464 Ivermectin results in decreased expression of NADK2 protein CTD PMID:32959892 Nadk2 Mouse lead(0) affects expression ISO RGD:1604237 6480464 Lead affects the expression of NADK2 mRNA CTD PMID:28903495 Nadk2 Mouse methapyrilene decreases expression ISO RGD:1306809 6480464 Methapyrilene results in decreased expression of NADK2 mRNA CTD PMID:30467583 Nadk2 Mouse methapyrilene increases expression ISO RGD:1306809 6480464 Methapyrilene results in increased expression of NADK2 protein CTD PMID:30467583 Nadk2 Mouse methimazole decreases expression ISO RGD:1306809 6480464 Methimazole results in decreased expression of NADK2 mRNA CTD PMID:30047161 Nadk2 Mouse methyl methanesulfonate decreases expression ISO RGD:1604237 6480464 Methyl Methanesulfonate results in decreased expression of NADK2 mRNA CTD PMID:23649840 Nadk2 Mouse methylmercury chloride decreases expression ISO RGD:1604237 6480464 methylmercuric chloride results in decreased expression of NADK2 mRNA CTD PMID:28001369 Nadk2 Mouse mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:1604237 6480464 [Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of NADK2 more ... CTD PMID:33872906 Nadk2 Mouse N-nitrosomorpholine decreases expression ISO RGD:1306809 6480464 N-nitrosomorpholine results in decreased expression of NADK2 protein CTD PMID:19716841 Nadk2 Mouse ozone multiple interactions ISO RGD:1604237 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of more ... CTD PMID:32699268 Nadk2 Mouse p-chloromercuribenzoic acid decreases expression ISO RGD:1604237 6480464 p-Chloromercuribenzoic Acid results in decreased expression of NADK2 mRNA CTD PMID:26272509 Nadk2 Mouse p-chloromercuribenzoic acid multiple interactions ISO RGD:1604237 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Nadk2 Mouse paracetamol decreases expression ISO RGD:1604237 6480464 Acetaminophen results in decreased expression of NADK2 mRNA CTD PMID:25704631 Nadk2 Mouse pentachlorophenol decreases expression EXP 6480464 Pentachlorophenol results in decreased expression of NADK2 mRNA CTD PMID:23892564 Nadk2 Mouse perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1604237 6480464 perfluorooctane sulfonic acid results in decreased expression of NADK2 mRNA CTD PMID:27153767 Nadk2 Mouse perfluorooctane-1-sulfonic acid multiple interactions EXP 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of NADK2 mRNA CTD PMID:36331819 Nadk2 Mouse phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of NADK2 mRNA CTD PMID:23091169 Nadk2 Mouse potassium chromate decreases expression ISO RGD:1604237 6480464 potassium chromate(VI) results in decreased expression of NADK2 mRNA CTD PMID:22079256 Nadk2 Mouse potassium chromate multiple interactions ISO RGD:1604237 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NADK2 mRNA CTD PMID:22079256 Nadk2 Mouse quercetin decreases expression ISO RGD:1604237 6480464 Quercetin results in decreased expression of NADK2 mRNA CTD PMID:21632981 Nadk2 Mouse resveratrol multiple interactions ISO RGD:1604237 6480464 [Coumestrol co-treated with Resveratrol] results in increased expression of NADK2 mRNA; [Plant Extracts co-treated with more ... CTD PMID:19167446|PMID:23557933 Nadk2 Mouse SB 431542 multiple interactions ISO RGD:1604237 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... CTD PMID:27188386 Nadk2 Mouse silver atom affects expression EXP 6480464 Silver affects the expression of NADK2 mRNA CTD PMID:27131904 Nadk2 Mouse silver(0) affects expression EXP 6480464 Silver affects the expression of NADK2 mRNA CTD PMID:27131904 Nadk2 Mouse sunitinib increases expression ISO RGD:1604237 6480464 Sunitinib results in increased expression of NADK2 mRNA CTD PMID:31533062 Nadk2 Mouse tetrachloromethane decreases expression ISO RGD:1306809 6480464 Carbon Tetrachloride results in decreased expression of NADK2 mRNA CTD PMID:31150632 Nadk2 Mouse tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of NADK2 mRNA CTD PMID:31919559 Nadk2 Mouse tetrachloromethane multiple interactions ISO RGD:1306809 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of NADK2 mRNA] CTD PMID:31150632 Nadk2 Mouse trichostatin A decreases expression ISO RGD:1604237 6480464 trichostatin A results in decreased expression of NADK2 mRNA CTD PMID:26272509 Nadk2 Mouse trichostatin A multiple interactions ISO RGD:1604237 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386 Nadk2 Mouse triphenyl phosphate affects expression ISO RGD:1604237 6480464 triphenyl phosphate affects the expression of NADK2 mRNA CTD PMID:37042841 Nadk2 Mouse triptonide affects expression EXP 6480464 triptonide affects the expression of NADK2 mRNA CTD PMID:33045310 Nadk2 Mouse uranium atom increases expression ISO RGD:1604237 6480464 Uranium results in increased expression of NADK2 mRNA CTD PMID:15672453 Nadk2 Mouse urethane decreases expression ISO RGD:1604237 6480464 Urethane results in decreased expression of NADK2 mRNA CTD PMID:28818685 Nadk2 Mouse valproic acid decreases methylation ISO RGD:1604237 6480464 Valproic Acid results in decreased methylation of NADK2 gene CTD PMID:29154799 Nadk2 Mouse valproic acid decreases expression ISO RGD:1604237 6480464 Valproic Acid results in decreased expression of NADK2 mRNA CTD PMID:23179753|PMID:26272509 Nadk2 Mouse valproic acid multiple interactions ISO RGD:1604237 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... CTD PMID:27188386